Fennec Pharmaceuticals Inc (FENC)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2022 | 03-2022 | 12-2021 | 09-2021 | 06-2021 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 14,915 | 18,259 | 21,100 | 24,335 | 27,293 |
| Other current assets | 149 | 154 | 253 | 412 | 372 |
| TOTAL | $15,554 | $19,128 | $22,387 | $25,979 | $28,074 |
| Non-Current Assets | |||||
| Other Non-Current Assets | 14 | 21 | 27 | 35 | 41 |
| TOTAL | $14 | $21 | $27 | $35 | $41 |
| Total Assets | $15,568 | $19,149 | $22,414 | $26,014 | $28,115 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 1,000 | 500 | N/A | N/A | N/A |
| Accounts payable and accrued liabilities | 1,743 | 1,224 | 777 | 1,154 | 677 |
| Accrued Expenses | 294 | 412 | 877 | 860 | 171 |
| TOTAL | $3,037 | $2,136 | $1,654 | $2,014 | $848 |
| Non-Current Liabilities | |||||
| Long Term Debt | 3,990 | 4,489 | 4,988 | 4,987 | 4,986 |
| TOTAL | $3,990 | $4,489 | $4,988 | $4,987 | $4,986 |
| Total Liabilities | $7,027 | $6,625 | $6,642 | $7,001 | $5,834 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 26,067 | 26,039 | 26,014 | 26,007 | 26,007 |
| Common Shares | 140,922 | 140,832 | 140,801 | 140,780 | 140,780 |
| Retained earnings | -188,254 | -183,182 | -179,486 | -175,059 | -170,874 |
| Other shareholders' equity | 1,243 | 1,243 | 1,243 | 1,243 | 1,243 |
| TOTAL | $8,541 | $12,524 | $15,772 | $19,013 | $22,281 |
| Total Liabilities And Equity | $15,568 | $19,149 | $22,414 | $26,014 | $28,115 |